β¨ Health Notices
8 SEPTEMBER NEW ZEALAND GAZETTE 2783
executed on the 22nd day of August 1994. A copy of the supplementary agreement is available for inspection without charge by any member of the public at the district office of the Ministry of Education.
Dated at Wellington this 23rd day of August 1994.
K. PHILLIPS, Senior Manager, National Operations.
go6531
Health
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Nicotine 10 mg/ml | Solution | Kabi Pharmacia Therapeutics AB, Helsingborg, Sweden | Nicorette Nasal Spray |
| Beclomethasone dipropionate | Spray (oral metered) | Orion Corporation Fermion, Orionintie 1, Espoo, Finland | Atomide 100 Inhaler |
| 100 mcg per actuation | |||
| Morphine sulphate 20 mg; | Capsules | Faulding Pharmaceuticals, Salisbury South, South Australia, | Kapanol |
| 50 mg, 100 mg | (sustained release) | Australia | |
| Note: Not to be marketed as substitutable for any other morphine sulphate product as if the two (2) products were bioequivalent. | |||
| Tenoxicam 20 mg | Tablet | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Suppository | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Powder for solution (milk) | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Tablet (effervescent) | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Tablet | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Suppository | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Powder for solution (milk) | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Tablet (effervescent) | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| Tenoxicam 20 mg | Powder for injection | F Hoffmann-La Roche Limited, Basle, Switzerland | Tilcotil |
| (glass vial and diluent) | |||
| Diclofenac sodium 0.1% w/v | Eye drops | Ciba Vision AG, Hettlingen, Switzerland | Voltaren Ophtha |
| Verapamil hydrochloride | Tablets | Knoll AG, Ludwigshafen, Germany | Isoptin SR |
| 120 mg, 240 mg | (sustained release) | ||
| Famotidine 10 mg | Tablet | Merck Sharp & Dohme Limited, Cramlington, Northumberland, | Pepcid AC |
| England | |||
| Apraclonidine hydrochloride | Ophthalmic solution | Alcon Laboratories Inc., Fort Worth, Texas, United States | Iopidine 0.5% Solution |
| 5.75 mg equivalent to apraclonidine base 5 mg per ml | and S A Alcon Couvreur N V, Puurs, Belgium |
Dated this 2nd day of September 1994.
C. LOVEACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
go6642
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1994, No 91
NZLII —
NZ Gazette 1994, No 91
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare2 September 1994
Medicines, Distribution, Consent, Medicines Act 1981
- C. Loveace, Director-General of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Consent, Medicines Act 1981